SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Indoco Remedies advances on receiving EU GMP Certification for Goa Plant III

16 Feb 2018 Evaluate

Indoco Remedies is currently trading at Rs. 271.55, up by 11.00 points or 4.22% from its previous closing of Rs. 260.55 on the BSE.

The scrip opened at Rs. 267.90 and has touched a high and low of Rs. 277.25 and Rs. 267.90 respectively. So far 4,220 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 317.00 on 24-Jan-2018 and a 52 week low of Rs. 179.00 on 31-May-2017.

Last one week high and low of the scrip stood at Rs. 279.00 and Rs. 258.00 respectively. The current market cap of the company is Rs. 2,497.00 crore.

The promoters holding in the company stood at 58.85%, while Institutions and Non-Institutions held 17.62% and 23.53% respectively.

Indoco Remedies has been granted an European GMP certification from Regulatory Authority of Hungary for its manufacturing facility for Non - Sterile products (Goa - Plant III), located at L-32, 33, 34 Verna Industrial Estate, Goa.

The EU GMP certification will enable the company to continue to export medicinal products to all European countries. The granted GMP certification will also continue to support exports of drug products to Canada, Australia, New Zealand and rest of the emerging territories as well.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Indoco Remedies Share Price

219.85 2.60 (1.20%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×